Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study-Reference-Cited by-同舟云学术

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study

Published:2015-10 Issue:10 Volume:26 Page:984-991
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Marshall A.D.,Micallef M.,Erratt A.,Telenta J.,Treloar C.,Everingham H.,Jones S.C.,Bath N.,How-Chow D.,Byrne J.,Harvey P.,Dunlop A.,Jauncey M.,Read P.,Collie T.,Dore G.J.,Grebely J.

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference34 articles.

1. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study;Alavi;Clinical Infectious Diseases,2013

2. Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study;Alavi;Journal of Viral Hepatitis,2015

3. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents;Alavi;Liver International,2014

4. Increasing public awareness about hepatitis C: Development and validation of the brief hepatitis C knowledge scale;Balfour;Scandinavian Journal of Caring Sciences,2009

5. The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test;Bush;Archives of Internal Medicine,1998

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of a nurse-delivered, community-based liver screening and assessment program for people with non-alcoholic fatty liver disease (LOCATE-NAFLD trial);2024-05-10

2. We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?;Expert Review of Molecular Diagnostics;2024-01-04

3. A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland;International Journal of Drug Policy;2023-10

4. Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days;Journal of Viral Hepatitis;2023-01-11

5. Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis;Interactive Journal of Medical Research;2022-08-23